Antiviral drug ganciclovir is a potent inhibitor of microglial proliferation and neuroinflammation

Journal of Experimental Medicine

Volumn 211, Issue 2, 2014, Pages 189-198

  Ding, Zhaoqing ^a   Mathur, Vidhu ^a   Ho, Peggy P ^a   James, Michelle L ^a   Lucin, Kurt M ^a   Hoehne, Aileen ^a   Alabsi, Haitham ^a   Gambhir, Sanjiv S ^a   Steinman, Lawrence ^a   Luo, Jian ^a,b   Wyss Coray, Tony ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; ANTIVIRAL AGENTS; BRAIN; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GANCICLOVIR; IMMUNOSUPPRESSIVE AGENTS; MICE; MICE, INBRED C57BL; MICROGLIA; OVALBUMIN; T-LYMPHOCYTE SUBSETS;

EID: 84893725541     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20120696     Document Type: Article

References (32)

1. Ajami, B., J.L. Bennett, C. Krieger, K.M. McNagny, and F.M. Rossi. 2011. Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool. Nat. Neurosci. 14:1142-1149. http://dx.doi .org/10.1038/nn.2887
2. Axtell, R.C., B.A. de Jong, K. Boniface, L.F. van der Voort, R. Bhat, P. De Sarno, R. Naves, M. Han, F. Zhong, J.G. Castellanos, et al. 2010. T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis. Nat. Med. 16:406- 412. http://dx.doi.org/10.1038/nm.2110
3. Banati, R.B., J. Newcombe, R.N. Gunn, A. Cagnin, F. Turkheimer, F. Heppner, G. Price, F. Wegner, G. Giovannoni, D.H. Miller, et al. 2000. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain. 123:2321-2337. http://dx.doi.org/10.1093/brain/123.11.2321
4. Bech, E., J. Lycke, P. Gadeberg, H.J. Hansen, C. Malmeström, O. Andersen, T. Christensen, S. Ekholm, S. Haahr, P. Höllsberg, et al. 2002. A randomized, double-blind, placebo-controlled MRI study of anti-herpes virus therapy in MS. Neurology. 58:31-36. http://dx.doi.org/10.1212/WNL.58.1.31
5. Bhaskar, K., M. Konerth, O.N. Kokiko-Cochran, A. Cardona, R.M. Ransohoff, and B.T. Lamb. 2010. Regulation of tau pathology by the microglial fractalkine receptor. Neuron. 68:19-31. http://dx.doi.org/10 .1016/j.neuron.2010.08.023
6. Boillée, S., K. Yamanaka, C.S. Lobsiger, N.G. Copeland, N.A. Jenkins, G. Kassiotis, G. Kollias, and D.W. Cleveland. 2006. Onset and progression in inherited ALS determined by motor neurons and microglia. Science. 312:1389-1392. http://dx.doi.org/10.1126/science.1123511
7. Chin, F.T., M. Namavari, J. Levi, M. Subbarayan, P. Ray, X. Chen, and S.S. Gambhir. 2008. Semiautomated radiosynthesis and biological evaluation of [18F]FEAU: a novel PET imaging agent for HSV1-tk/sr39tk reporter gene expression. Mol. Imaging Biol. 10:82-91. http://dx.doi.org/ 10.1007/s11307-007-0122-3
8. Culver, K.W., Z. Ram, S. Wallbridge, H. Ishii, E.H. Oldfield, and R.M. Blaese. 1992. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science. 256:1550-1552. http:// dx.doi.org/10.1126/science.1317968
9. Faulds, D., and R.C. Heel. 1990. Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections. Drugs. 39:597-638. http://dx.doi.org/10.2165/00003495- 199039040-00008
10. Fillat, C., M. Carrió, A. Cascante, and B. Sangro. 2003. Suicide gene therapy mediated by the Herpes Simplex virus thymidine kinase gene/ Ganciclovir system: fifteen years of application. Curr. Gene Ther. 3:13-26. http://dx.doi.org/10.2174/1566523033347426
11. Friedman, J.E., J.B. Zabriskie, C. Plank, D. Ablashi, J. Whitman, B. Shahan, R. Edgell, M. Shieh, O. Rapalino, R. Zimmerman, and D. Sheng. 2005. A randomized clinical trial of valacyclovir in multiple sclerosis. Mult. Scler. 11:286-295. http://dx.doi.org/10.1191/1352458505ms1185oa
12. Geissmann, F., M.G. Manz, S. Jung, M.H. Sieweke, M. Merad, and K. Ley. 2010. Development of monocytes, macrophages, and dendritic cells. Science. 327:656-661. http://dx.doi.org/10.1126/science.1178331
13. Genentech. 2010. Cytovene-IV (Ganciclovir Sodium for Injection) for Intravenous Infusion Only. Genentech, South San Francisco, CA. http://www .gene.com/download/pdf/cytovene_prescribing.pdf (accessed October 15, 2013).
14. Heppner, F.L., M. Greter, D. Marino, J. Falsig, G. Raivich, N. Hövelmeyer, A. Waisman, T. Rülicke, M. Prinz, J. Priller, et al. 2005. Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat. Med. 11:146-152. http://dx.doi.org/10.1038/nm1177
15. Hilas, O., P.N. Patel, and S. Lam. 2010. Disease modifying agents for multiple sclerosis. Open Neurol J. 4:15-24. http://dx.doi.org/10.2174/ 1874205X01004010015
16. Killestein, J., and C.H. Polman. 2011. Determinants of interferon β efficacy in patients with multiple sclerosis. Nat Rev Neurol. 7:221-228. http:// dx.doi.org/10.1038/nrneurol.2011.22
17. Loening, A.M., and S.S. Gambhir. 2003. AMIDE: a free software tool for multimodality medical image analysis. Mol. Imaging. 2:131-137. http:// dx.doi.org/10.1162/153535003322556877
18. Lublin, F.D., M. Lavasa, C. Viti, and R.L. Knobler. 1987. Suppression of acute and relapsing experimental allergic encephalomyelitis with mitoxantrone. Clin. Immunol. Immunopathol. 45:122-128. http://dx.doi.org/ 10.1016/0090-1229(87)90118-8
19. Lucin, K.M., and T. Wyss-Coray. 2009. Immune activation in brain aging and neurodegeneration: too much or too little? Neuron. 64:110-122. http:// dx.doi.org/10.1016/j.neuron.2009.08.039
20. Luo, J., A.H. Lin, E. Masliah, and T. Wyss-Coray. 2006. Bioluminescence imaging of Smad signaling in living mice shows correlation with excitotoxic neurodegeneration. Proc. Natl. Acad. Sci. USA. 103:18326-18331. http://dx.doi.org/10.1073/pnas.0605077103
21. Luo, J., P.P. Ho, M.S. Buckwalter, T. Hsu, L.Y. Lee, H. Zhang, D.K. Kim, S.J. Kim, S.S. Gambhir, L. Steinman, and T. Wyss-Coray. 2007. Glia-dependent TGF-beta signaling, acting independently of the TH17 pathway, is critical for initiation of murine autoimmune encephalomyelitis. J. Clin. Invest. 117:3306-3315. http://dx.doi.org/10.1172/JCI31763
22. Lycke, J., B. Svennerholm, E. Hjelmquist, L. Frisén, G. Badr, M. Andersson, A. Vahlne, and O. Andersen. 1996. Acyclovir treatment of relapsing-remitting multiple sclerosis. A randomized, placebo-controlled, double-blind study. J. Neurol. 243:214-224. http://dx.doi.org/10.1007/BF00868517
23. Matthews, T., and R. Boehme. 1988. Antiviral activity and mechanism of action of ganciclovir. Rev. Infect. Dis. 10:S490-S494. http://dx.doi.org/ 10.1093/clinids/10.Supplement_3.S490
24. Min, J.J., M. Iyer, and S.S. Gambhir. 2003. Comparison of [18F]FHBG and [14C]FIAU for imaging of HSV1-tk reporter gene expression: adenoviral infection vs stable transfection. Eur. J. Nucl. Med. Mol. Imaging. 30:1547- 1560. http://dx.doi.org/10.1007/s00259-003-1238-6
25. Moliné-Velázquez, V., H. Cuervo, V. Vila-Del Sol, M.C. Ortega, D. Clemente, and F. de Castro. 2011. Myeloid-derived suppressor cells limit the inflammation by promoting T lymphocyte apoptosis in the spinal cord of a murine model of multiple sclerosis. Brain Pathol. 21:678-691. http:// dx.doi.org/10.1111/j.1750-3639.2011.00495.x
26. Paxinos, G., and K.B.J. Franklin. 2001. The Mouse Brain in Stereotaxic Coordinates. Second edition. Academic Press, San Diego. 296 pp.
27. Ponomarev, E.D., L.P. Shriver, K. Maresz, and B.N. Dittel. 2005. Microglial cell activation and proliferation precedes the onset of CNS autoimmunity. J. Neurosci. Res. 81:374-389. http://dx.doi.org/10.1002/jnr.20488
28. Ponomarev, E.D., T. Veremeyko, N. Barteneva, A.M. Krichevsky, and H.L. Weiner. 2011. MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-α-PU.1 pathway. Nat. Med. 17:64-70. http://dx.doi.org/10.1038/nm.2266
29. Prinz, M., H. Schmidt, A. Mildner, K.P. Knobeloch, U.K. Hanisch, J. Raasch, D. Merkler, C. Detje, I. Gutcher, J. Mages, et al. 2008. Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system. Immunity. 28:675-686. http://dx.doi .org/10.1016/j.immuni.2008.03.011
30. Saijo, K., and C.K. Glass. 2011. Microglial cell origin and phenotypes in health and disease. Nat. Rev. Immunol. 11:775-787. http://dx.doi.org/10.1038/nri3086
31. Saijo, K., J.G. Collier, A.C. Li, J.A. Katzenellenbogen, and C.K. Glass. 2011. An ADIOL-ERβ-CtBP transrepression pathway negatively regulates microglia- mediated inflammation. Cell. 145:584-595. http://dx.doi.org/10 .1016/j.cell.2011.03.050
32. Schulze-Topphoff, U., A. Shetty, M. Varrin-Doyer, N. Molnarfi, S.A. Sagan, R.A. Sobel, P.A. Nelson, and S.S. Zamvil. 2012. Laquinimod, a quinoline- 3-carboxamide, induces type II myeloid cells that modulate central nervous system autoimmunity. PLoS ONE. 7:e33797. http://dx.doi.org/10 .1371/journal.pone.0033797